Latest News

Noah Holdings' H1 2026 CIO Report Outlines the Emergence of AI Infrastructure as a Critical Long-Term Asset for Wealth Allocation

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), an established wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese high-net...

2026-01-20 18:35 18539

Envision Partners with Kazakhstan Samruk-Kazyna Invest to Expand Energy Storage and Renewable Growth in Central Asia

ABU DHABI, UAE, Jan. 20, 2026 /PRNewswire/ -- Envision Energy, a global leader in green technology, announced a Joint Development Agreement with Samruk-Kazyna Invest (SKI), the investment arm of Kazakhstan's sovereign wealth fund, for the localized production of BESS at Envision Global Tech Day 2...

2026-01-20 18:22 10820

Infinix NOTE Edge's 'Ten-Dimensional Reveal' Holographic Spectacle: Ushering in a New Era of 10 Dimensions of Excellence

A Spectacular Beachside Light Art Show Merges Creativity, Performance, and Innovation to Showcase NOTE Edge's Unrivaled Design, Performance, and All-Scenario Excellence JAKARTA, Indonesia, Jan. 20, 2026 /PRNewswire/ -- On January 15, Infinix transformed aJakarta beachfront into a breathtaking im...

2026-01-20 18:22 6175

DP WORLD SURVEY: TRADE LEADERS UPBEAT ON 2026 DESPITE RISING BARRIERS

Global Trade Observatory Annual Outlook: 94% expect 2026 growth to match or exceed 2025 despite tariffs, costs and policy uncertainty DAVOS, Switzerland, Jan. 20, 2026 /PRNewswire/ -- The global trade outlook looks fragile. Business confidence does not. That's the core finding of DP World's new ...

2026-01-20 18:14 4584

GENEIII Sets the Global Benchmark for Ergothioneine with Pharmaceutical-Grade Purity and Human Clinical Validation

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- On January 9th, GENEIII reaffirmed its global leadership in ergothioneine production and scientific validation at the "Research Without Borders • Tracing the Source with GENEIII" Global Evidence-Based Journey. GENEIII joined forces with core partners to v...

2026-01-20 18:09 4530

FITUR 2026 brings together global tourism with more than 160 countries and 10,000 companies

Mexico joins FITUR 2026 as Partner Country in an edition bringing together 967 main exhibitors and marking an 11% rise in international participation. The Knowledge Hub, FITUR Experience and the first International Summit on Communication and Tourism introduce the main innovations of a 46th editi...

2026-01-20 18:00 6927

ZTO Express Holds 2026 National Network Conference

SHANGHAI, Jan. 20, 2026 /PRNewswire/ -- On January 20, 2026, ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"), a leading and fast-growing express delivery enterprise in China, convened its National Network Conference at its headquarters in Shanghai. The conference con...

2026-01-20 18:00 8927

Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia

JAKARTA, Indonesia and KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ -- Global performance sportswear brand Xtep Group has inaugurated its 2026 Southeast Asia expansion with the debut of new, experience-driven hubs in Jakarta and Kuala Lumpur. More than mere retail openings, these launches ...

2026-01-20 17:49 18261

AI/works™ heralds a new era of Agile and next-generation software development

Thoughtworks' agentic development platform developed to support both technology modernization and greenfield development. CHICAGO, Jan. 20, 2026 /PRNewswire/ -- Thoughtworks, a global technology consultancy that integrates design, engineering and AI to drive digital innovation, today announced t...

2026-01-20 17:00 5765

Multilingual AI Voice Agent was launched by Zadarma

LONDON, Jan. 20, 2026 /PRNewswire/ -- Zadarma, a global VoIP service provider, announces the launch of the Zadarma AI Voice Agent. This virtual assistant handles calls, uses a natural, realistic voice, and communicates with customers during and outside business hours. The AI voice agent uses you...

2026-01-20 17:00 6873

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous (SQ) dosing in humans. - ASC37's average in vitro activity was approximately 5-, 4-, and 4-fold more potent t...

2026-01-20 17:00 5732

AI/works™ heralds a new era of Agile and next-generation software development

Thoughtworks' agentic development platform developed to support both technology modernization and greenfield development. CHICAGO, Jan. 20, 2026 /PRNewswire/ -- Thoughtworks, a global technology consultancy that integrates design, engineering and AI to drive digital innovation, today announced t...

2026-01-20 17:00 3270

GIBO Advances Toward Integrated Autonomous Mobility Systems, Building a Unified AI Stack Across Air and Ground Platforms

KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO),Asia's leading innovation-driven AI ecosystem, today announced the next evolution of its AI mobility roadmap, advancing theGIBO.ai Calculation Engine toward a unified, cross-domain intelligence stack supportin...

2026-01-20 17:00 7254

INVITATION FOR EXPRESSION OF INTEREST - For Divestiture of 'Canwill Holdings (Pvt) Ltd'

COLOMBO, Sri Lanka, Jan. 20, 2026 /PRNewswire/ -- The Government of Sri Lanka (GoSL) intends to divest the 100% shareholding in Canwill, the parent company to Sinolanka Hotels & Spa (Pvt) Ltd (Sinolanka) and Helanco Hotels & Spa (Pvt) Ltd (Helanco). GoSL will implement this divestiture through th...

2026-01-20 16:30 6080

SmallRig Signals Strategic Shift at CES Debut, Reframing Imaging Innovation Around Everyday Creation

LAS VEGAS, Jan. 20, 2026 /PRNewswire/ -- SmallRig, a global specialized provider of imaging solutions, made its first appearance at CES 2026 from January 6 to 9, marking a milestone moment in its global strategy. Reimagining the CES Booth as a Co-Creation Hub Alongside the international debut of...

2026-01-20 16:19 5461

Merck and ChemLex Sign Memorandum of Understanding to Advance Automated Chemistry and Technological Innovation

Strategic collaboration establishes a framework to integrate automated experimentation and advanced chemistry workflows to accelerate research and discovery in Life Science and Electronics SINGAPORE and SHANGHAI, Jan. 20, 2026 /PRNewswire/ -- Merck, a leading science and technology company, and ...

2026-01-20 16:17 5831

Infosys is the Fastest Growing IT Services Brand Globally with a CAGR of 15% in Brand Value

Top 3 Most Valuable IT Services Brand In the world. A Top 100 Brand across categories in Brand Strength DAVOS, Switzerland, Jan. 20, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consul...

2026-01-20 16:13 4204

Fushi Tech and Commonwealth Concepts Singapore Partner to Launch Integrated One-Stop Digital Platform for F&B Excellence

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Fushi Tech, a global provider of integrated AI & digital solutions for merchants, today announced a strategic partnership with Commonwealth Concepts, Singapore's renowned food and lifestyle group. Through its Fynix suite of F&B solutions, Fushi Tech will r...

2026-01-20 16:07 6114

Nuvoton Releases High-Power Ultraviolet Laser Diode (379 nm, 1.0 W)

KYOTO, Japan, Jan. 20, 2026 /PRNewswire/ -- Nuvoton Technology Corporation Japan (hereinafter "NTCJ") announced on January 20 the start of mass production of its high-power ultraviolet semiconductor laser (379 nm, 1.0 W), which delivers industry-leading (*) optical output in a 9.0-mm diameter CAN...

2026-01-20 16:00 4704

Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology

DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. Under the terms of the agreement, Tesaro will acquire world-wide rights to use ALT-B4, Alteog...

2026-01-20 15:55 6389